Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
---|
02/01/2007 | WO2007012651A1 Isotopically substituted pantoprazole |
02/01/2007 | WO2007012650A1 Isotopically substituted proton pump inhibitors |
02/01/2007 | WO2006132811A3 Ampa receptor potentiators |
02/01/2007 | WO2006065458A3 Methods for producing a hexadentate bimetallic complex |
02/01/2007 | WO2006002802A8 Phenyl derivatives comprising an acetylene group |
02/01/2007 | US20070027321 Bipyridyl amines and ethers as modulators of metabotropic glutamate receptor-5 |
02/01/2007 | US20070027205 Diarylmethyl derivatives as potassium channel modulators |
02/01/2007 | US20070027192 N-{[1-(Methylamino)cyclopropyl]methyl}pyridin-3-amine dihydrochloride; treatment of neuropathologies associated with cerebral ageing, of mood disorders, of pain and of tobacco withdrawal; selective nicotinic ligands of the central receptor sub-type alpha 4 beta 2 |
02/01/2007 | US20070027191 N,2-dimethyl-1-[(3-pyridinyloxy)methyl]cyclopropanamine; nicotinic receptors of type alpha 4 beta 2 ligand; neurodegenerative diseases: Alzheimer's, Parkinson's, Pick's, attention-deficit hyperactivity syndrome |
02/01/2007 | US20070027190 Antibacterial fab i inhibitors |
02/01/2007 | US20070027185 inhibitor of factor Xa and/or thrombin; anticoagulantsto treat thromboembolic disorders, myocardial ischemia, myocardial infarction and cerebral thrombosis; N-(5-chloropyridin-2-yl)-3-[2-(piperidin-4-yloxy)-4-(pyrrolidin-1-yl)benzoylamino]pyridine-4-carboxamide; high bioavailability; acylation |
02/01/2007 | US20070027174 Phenylalanine Enamide Derivatives |
02/01/2007 | US20070027159 Therapeutic agents useful for treating pain |
02/01/2007 | US20070027158 High affinity small molecule C5a receptor modulators |
02/01/2007 | US20070027154 Insecticide for agricultural or horticultural use and method of use thereof |
02/01/2007 | US20070027147 Biarylurea derivatives |
02/01/2007 | US20070027118 Novel compounds of amino sulfonyl derivatives |
02/01/2007 | US20070026535 Metal chelator that can be linked to a probe moiety via a hydrazone linkage, hydrazone linkage is readily formed in aqueous solution and is stable without further chemical transformation, making it particularly suitable for use with proteins, nucleic acids, and the like |
02/01/2007 | US20070026384 Detection of transmembrane potentials by optical methods |
02/01/2007 | US20070023739 DAST twin crystal, process for producing the same, and use thereof |
02/01/2007 | CA2616377A1 Nitrocatechol derivatives as comt inhibitors |
02/01/2007 | CA2615678A1 Isotopically substituted pantoprazole |
02/01/2007 | CA2615670A1 Isotopically substituted proton pump inhibitors |
01/31/2007 | EP1748046A2 Inhibitors of histone deacetylase |
01/31/2007 | EP1748043A1 Polysubstituted 1,1-pyridinyloxycyclopropanamine derivatives, process for their préparation and pharmaceutical compositions containing them |
01/31/2007 | EP1747210A1 3- or 4-monosubstituted phenol and thiophenol derivatives useful as h3 ligands |
01/31/2007 | EP1747196A2 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
01/31/2007 | EP1747191A1 Substituted cyclohexyl-1,4-diamine derivatives with a chain extension |
01/31/2007 | CN1906187A 5-fluoro-, chloro- and cyano-pyridin-2-yl-tetrazoles as ligands of the metabotropic glutamate receptor-5 |
01/31/2007 | CN1906183A N-acylsulfonamide apoptosis promoters |
01/31/2007 | CN1906167A Novel pyridine derivative and pyrimidine derivative (2) |
01/31/2007 | CN1906166A Novel pyridine derivative and pyrimidine derivative (1) |
01/31/2007 | CN1906165A Novel herbicides |
01/31/2007 | CN1906164A 组织蛋白酶半胱氨酸蛋白酶抑制剂 Cathepsin cystatin |
01/31/2007 | CN1906154A Aminoalcohol derivatives |
01/31/2007 | CN1906143A Method of deuteration using mixed catalyst |
01/31/2007 | CN1905873A Bicyclic inhibitors of MEK and methods of use thereof |
01/31/2007 | CN1905872A Amino substituted pyridinyl methanone compounds useful in treating kinase disorders |
01/31/2007 | CN1903845A Preparation method of 3-cyanopyridine |
01/31/2007 | CN1903844A New polysubstituted 1, 1pyridylaminocyclopropanamine compounds,a process for their preparation and pharmaceutical compositions containing them |
01/31/2007 | CN1903843A New polysubstituted 1,1-pyridyloxycyclopropanamine compounds, a process for their preparation and pharmaceutical compositions containing them |
01/31/2007 | CN1903842A Preparation method of 3-methyl pyridine |
01/31/2007 | CN1903841A Preparation method of 3-methyl piperidine |
01/31/2007 | CN1297546C Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same |
01/31/2007 | CN1297540C New derivatives of pyridilethanol (phenylethyl) amines as cholesterol biosynthesis inhibitors, procedures of their preparation and pharmaceutical preparations which they contain |
01/30/2007 | US7169957 Substantially spherical supramolecular assemblies |
01/30/2007 | US7169950 Reacting ozone with unsaturated compound |
01/30/2007 | US7169932 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses, material for their synthesis |
01/30/2007 | US7169928 central nervous system disorders; Alzheimer's disease; attention deficit disorders; cognition activators; psychological disorders; antidepressants |
01/30/2007 | US7169796 Polyarylcarboxamides useful as lipid lowering agents |
01/30/2007 | US7169791 Inhibitors of tyrosine kinases |
01/30/2007 | US7169785 e.g., 2-{[4-(Cyclohexylmethyl-amino)-6-(3-fluoro-4-methoxy-phenylamino)-[1,35]triazin-2-ylamino]-methyl}-cyclopentanone; treating unwanted cellular proliferation, an inflammation mediated disease, or a hyperproliferative disease, or modulating a glycosidase enzyme |
01/30/2007 | US7169779 Inhibitors of p38 |
01/30/2007 | US7169446 photocurable ink composition for ink jet recording containing a cation polymerizable oxetane compound with high reactivity which can provide a high quality image, and an image formation method employing the photocurable ink composition |
01/30/2007 | CA2440383C 7,9-substituted tetracycline compounds |
01/30/2007 | CA2238316C N-([1,2,4]triazoloazinyl)benzenesulfonamide and pyridinesulfonamide compounds and their use as herbicides |
01/30/2007 | CA2228939C Didepsipeptide-based endoparasiticides, new didepsipeptides and process for preparing the same |
01/30/2007 | CA2163747C Novel 1-phenylalkanone 5-ht4 receptor ligands |
01/28/2007 | CA2552831A1 Polysubstitute 1,1-pyridinylaminocyclopropanamine compounds, the process for preparing them and the pharmaceutical formulations that contain them |
01/28/2007 | CA2552827A1 Polysubstitute 1-1-pyridinyloxycyclopropanamine compounds, the process for preparing them and the pharmaceutical formulations that contain them |
01/25/2007 | WO2007010744A1 Process for production of thiocarbamate derivative |
01/25/2007 | WO2007010653A1 Salt molten at room temperature and display device |
01/25/2007 | WO2007010463A2 2-amino-5-aminomethyl-phenol derivatives and agent for coloring keratin fibers comprising these derivatives |
01/25/2007 | WO2007010222A2 Therapeutic agents |
01/25/2007 | WO2007009977A1 Polymerisation catalyst system based on dioxime ligands |
01/25/2007 | WO2007009904A1 Catalyst with bimodal distribution of the particles of the catalytically active material, method for the production thereof and for the regeneration thereof and the use of the catalyst |
01/25/2007 | WO2007009635A1 Phenyl substituted piperazine-derivatives as inhibitors of plaminogenic activator inhibitors-i (pai-i) |
01/25/2007 | WO2006074330A3 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
01/25/2007 | US20070021606 Therapeutic compounds |
01/25/2007 | US20070021494 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
01/25/2007 | US20070021473 Novel ligand activators of the RAR receptors and pharmaceutical/cosmetic applications thereof |
01/25/2007 | US20070021472 N-(5-bromo-2-pyridinyl)-(2-4-[(2-aminosulfonyl)phenyl]phenylcarbonylamino)phenylcarboxamide; potent and highly selective inhibitors; coagulation disorders; antithrombotic agents; diagnostic reagents; good bioavailability and/or solubility |
01/25/2007 | US20070021471 Crystalline N-(2-((4-Hydroxyphenyl)amino)pyridin-3-yl)-4-methoxybenzenesulfonamide ethanolates |
01/25/2007 | US20070021470 Crystalline N-(2-((4-Hydroxyphenyl)amino)pyridin-3-yl)-4-methoxybenzenesulfonamide methanolates |
01/25/2007 | US20070021426 Derivatives of heteroaryl-alkylcarbamates, methods for their preparation and use thereof as fatty acid amido hydrolase enzyme inhibitors |
01/25/2007 | US20070021424 e.g. 2-(methylamino)-2-oxoethyl {2-[(4-chlorophenyl)-oxy]ethyl}carbamate; fatty acid amide hydrolase inhibitor; cannabinoid and vanilloid receptors blocking agent; analgesic, antiinflammatory, anticarcinogenic, anxiolytic agent, neurodegenerative diseases, antidepressant |
01/25/2007 | US20070021354 Viricides; immunomoderator; mixture with other Aids drugs |
01/25/2007 | US20070020479 Luminescent-polymer composition |
01/25/2007 | US20070020182 Quaternary nitrogen heterocyclic boronic acid-containing compounds sensitive to glucose and fructose; contact lens; radiometers; kits; ophthalmic sensors |
01/25/2007 | DE102005034262A1 New N-phenyl pyridinecarboxamide derivatives, useful for the treatment and prevention of thrombotic disease, are inhibitors of plasminogen activator inhibitor-1 |
01/25/2007 | DE102005033371A1 Substituierte Pyridocarboxamide Substituted Pyridocarboxamide |
01/25/2007 | CA2614939A1 Phenyl substituted piperazine-derivatives as inhibitors of plaminogenic activator inhibitors-i (pai-i) |
01/24/2007 | EP1746111A1 Polymerisation catalyst system based on dioxime ligands |
01/24/2007 | EP1746089A1 Process for the preparation of 2-cyanopyridine derivatives |
01/24/2007 | EP1746088A1 2-Amino-5-aminomethyl-phenol derivatives and agent for coloring keratin fibers comprising these derivatives |
01/24/2007 | EP1745800A1 Novel blt2-mediated disease, and blt2 binding agent and compound |
01/24/2007 | EP1745042A1 Diarylamine derivatives as calcium channel blockers |
01/24/2007 | EP1745037A1 Indolylmaleimide derivatives as pkc inhibitors |
01/24/2007 | EP1745023A1 Process for producing bipyridinium compound |
01/24/2007 | EP1745022A1 Histone deacetylase inhibitor prodrugs |
01/24/2007 | EP1745009A1 Heteroaryl substituted cyclohexyl-1,4-diamine derivatives |
01/24/2007 | EP1745006A2 Methods of 1,3-enyne preparation using copper (i) catalysts |
01/24/2007 | EP1745003A1 Novel compounds, their preparation and use |
01/24/2007 | EP1745002A1 Novel compounds, their preparation and use |
01/24/2007 | EP1744745A1 Pharmaceutical nitrones |
01/24/2007 | EP1551360B1 6-alkoxy-2,3-diaminopyridine couplers in which the position 2 amino radical is a disubstituted amino radical and use of said couplers for the dyeing of keratinous fibres |
01/24/2007 | EP0968206B8 N-heterocyclic derivatives as nos inhibitors |
01/24/2007 | CN1902178A Therapeutic agents useful for treating pain |
01/24/2007 | CN1902171A Benzylether amine compounds useful as CCR-5 antagonists |
01/24/2007 | CN1901971A Cyclopropane compounds and pharmaceutical use thereof |